LightDeck Diagnostics was awarded a $5.65 million contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services (HHS), to develop an rapid antigen test to detect SARS-CoV-2.
The U.S. Food and Drug Administration is alerting clinical laboratory staff and healthcare providers that false positive results can occur with Covid-19 antigen tests.
Becton Dickinson is investigating reports from U.S. nursing homes that the company’s rapid coronavirus testing equipment is producing false-positive results.
Qiagen readies launch of rapid COVID-19 antigen test (Reuters) – German diagnostic test maker Qiagen on Tuesday said it planned to launch a COVID-19 antigen test that can provide results in 15 minutes and test about 30 samples in an hour. The company said it will launch two versions of the antigen test, one for […]
Researchers are developing simpler Covid-19 diagnostic tests for use outside of labs in an effort to make mass testing available, fast and inexpensive.